Hyperliquid Strategies Inc. (PURR)
NASDAQ: PURR · Real-Time Price · USD
3.680
+0.080 (2.22%)
At close: Dec 5, 2025, 4:00 PM EST
3.650
-0.030 (-0.82%)
After-hours: Dec 5, 2025, 7:55 PM EST
2.22% (1D)
| Market Cap | 467.45M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| Shares Out | 127.03M |
| EPS (ttm) | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,289,417 |
| Open | 3.750 |
| Previous Close | 3.600 |
| Day's Range | 3.445 - 3.750 |
| 52-Week Range | 3.330 - 4.650 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About PURR
Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company was incorporated in 2025 and is based in New York, New York. [Read more]
Founded 2025
Country United States
Stock Exchange NASDAQ
Ticker Symbol PURR
News
Ex-Barclays CEO unpacks Hyperliquid: ‘The FUTURE of finance'
Hyperliquid Strategies Inc. chairman Bob Diamond and Hyperliquid Stategies Inc. CEO David Schamis comment on the future of Hyperliquid Strategies Inc. on ‘The Claman Countdown.'
2 days ago - Fox Business
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Hyperliquid Strategies Common Stock Expected to Begin Trading on Nasdaq on Wednesday, December 3 Under the Ticker “PURR” Hyperliquid Strategies Common Stock Expected to Begin Trading on Nasdaq on Wedn...
Other symbols: SONN
3 days ago - GlobeNewsWire